Hypodermic Needles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Hypodermic Needles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


The global hypodermic needles market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028.

Hypodermic needles refer to thin, hollow needles used with a syringe to inject substances into the body. They also assist in extracting fluids from the body, such as taking a blood sample from a vein in venipuncture. They are typically manufactured using stainless-steel tubes through the tube drawing process. Hypodermic needles can also be utilized to provide medications that cannot be ingested orally because they cannot be absorbed easily (like insulin) or potentially harm the patient's liver. Moreover, they have an extremely smooth and sharp surface which prevents and minimizes contamination during inoculation of a sterile substrate. As a result, hypodermic needles find extensive applications in the healthcare sector and research environments requiring sterile conditions.

Hypodermic Needles Market Trends:
Hypodermic needles are widely used by medical professionals, physicians, dentists, and paramedics for rapid intradermal delivery of liquids in case of emergencies, vaccination, administration of drugs, and blood sample collection, which represents the primary factor driving the market growth. Additionally, the widespread prevalence of infections and chronic diseases, such as cancer, diabetes, and cardiovascular disorders, has escalated the demand for vaccines and injectable drugs. Along with this, the ongoing vaccination campaigns to curb the spread of coronavirus disease (COVID-19) across the globe are catalyzing the demand for hypodermic needles. Besides this, the implementation of stringent regulations by governments of various countries that mandate the use of safety needles to prevent needle re-usage and mitigate the risk of infections is propelling the market growth. Furthermore, several leading manufacturers are developing precision-engineered hypodermic needles to enhance patient comfort in parenteral therapies and reduce penetration resistance. They are also making heavy investments in automated systems for inspection and testing processes to meet the quality standards and ensure the safe administration of medications. Other factors, including the growing need to prevent needle-stick injuries, surging cases of blood-borne diseases, increasing blood donations, improving healthcare infrastructure, and technological advancements, are also creating a favorable market outlook.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hypodermic needles market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, application and end user.

Breakup by Product Type:

Safety Hypodermic Needles
Non-Safety Hypodermic Needles

Breakup by Application:

Drug Delivery
Vaccination
Blood Specimen Collection

Breakup by End User:

Hospitals and Clinics
Ambulatory Surgical Centers
Diabetic Patients
Family Practices
Psychiatrics
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.) and Terumo Corporation.

Report Coverage:

Key Questions Answered in This Report:
How has the global hypodermic needles market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global hypodermic needles market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global hypodermic needles market and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hypodermic Needles Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Safety Hypodermic Needles
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Non-Safety Hypodermic Needles
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Drug Delivery
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Vaccination
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Blood Specimen Collection
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Diabetic Patients
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Family Practices
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Psychiatrics
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
 9.1.1.1 Market Trends
 9.1.1.2 Market Forecast
9.1.2 Canada
 9.1.2.1 Market Trends
 9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
 9.2.1.1 Market Trends
 9.2.1.2 Market Forecast
9.2.2 Japan
 9.2.2.1 Market Trends
 9.2.2.2 Market Forecast
9.2.3 India
 9.2.3.1 Market Trends
 9.2.3.2 Market Forecast
9.2.4 South Korea
 9.2.4.1 Market Trends
 9.2.4.2 Market Forecast
9.2.5 Australia
 9.2.5.1 Market Trends
 9.2.5.2 Market Forecast
9.2.6 Indonesia
 9.2.6.1 Market Trends
 9.2.6.2 Market Forecast
9.2.7 Others
 9.2.7.1 Market Trends
 9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
 9.3.1.1 Market Trends
 9.3.1.2 Market Forecast
9.3.2 France
 9.3.2.1 Market Trends
 9.3.2.2 Market Forecast
9.3.3 United Kingdom
 9.3.3.1 Market Trends
 9.3.3.2 Market Forecast
9.3.4 Italy
 9.3.4.1 Market Trends
 9.3.4.2 Market Forecast
9.3.5 Spain
 9.3.5.1 Market Trends
 9.3.5.2 Market Forecast
9.3.6 Russia
 9.3.6.1 Market Trends
 9.3.6.2 Market Forecast
9.3.7 Others
 9.3.7.1 Market Trends
 9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
 9.4.1.1 Market Trends
 9.4.1.2 Market Forecast
9.4.2 Mexico
 9.4.2.1 Market Trends
 9.4.2.2 Market Forecast
9.4.3 Others
 9.4.3.1 Market Trends
 9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10  SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13  Price Analysis
14  Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 B. Braun Melsungen AG
 14.3.1.1 Company Overview
 14.3.1.2 Product Portfolio
 14.3.1.3 SWOT Analysis
14.3.2 Becton Dickinson and Company
 14.3.2.1 Company Overview
 14.3.2.2 Product Portfolio
 14.3.2.3 Financials
 14.3.2.4 SWOT Analysis
14.3.3 Cardinal Health Inc.
 14.3.3.1 Company Overview
 14.3.3.2 Product Portfolio
 14.3.3.3 Financials
 14.3.3.4 SWOT Analysis
14.3.4 Connecticut Hypodermics Inc.
 14.3.4.1 Company Overview
 14.3.4.2 Product Portfolio
14.3.5 EXELINT International Co.
 14.3.5.1 Company Overview
 14.3.5.2 Product Portfolio
14.3.6 Hi-Tech Syringes
 14.3.6.1 Company Overview
 14.3.6.2 Product Portfolio
14.3.7 McKesson Corporation
 14.3.7.1 Company Overview
 14.3.7.2 Product Portfolio
 14.3.7.3 Financials
 14.3.7.4 SWOT Analysis
14.3.8 Medline Industries LP
 14.3.8.1 Company Overview
 14.3.8.2 Product Portfolio
 14.3.8.3 SWOT Analysis
14.3.9 Nipro Corporation
 14.3.9.1 Company Overview
 14.3.9.2 Product Portfolio
 14.3.9.3 Financials
 14.3.9.4 SWOT Analysis
14.3.10 Retractable Technologies Inc.
 14.3.10.1 Company Overview
 14.3.10.2 Product Portfolio
 14.3.10.3 Financials
14.3.11 Smiths Medical Inc. (ICU Medical Inc.)
 14.3.11.1 Company Overview
 14.3.11.2 Product Portfolio
 14.3.11.3 SWOT Analysis
14.3.12 Terumo Corporation
 14.3.12.1 Company Overview
 14.3.12.2 Product Portfolio
 14.3.12.3 Financials
 14.3.12.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings